Application of bromegrass CYP71D55 gene

By identifying and applying the CYP71D55 gene, its expression level was detected to identify the resistance of CYP71D55 gene to sulfonamide carbonyltriazolinone herbicides, the management problem of CYP71D55 gene was solved and scientific resistance was provided. Sex identification and governance methods significantly improve the accuracy and efficiency of resistance management.

CN118932105APending Publication Date: 2024-11-12INST OF PLANT PROTECTION CHINESE ACAD OF AGRI SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411180525.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively solve the problem of quinoxine resistance to herbicides, especially the difficulty in treating resistance to sulfonamide carbonyltriazolinone herbicides.

Method used

By identifying and applying the CYP71D55 gene, its expression level is detected to identify the resistance of CYP71D55 to sulfonamide carbonyltriazolinone herbicides, providing a simple, sensitive and specific method to identify and cope with it.

Benefits of technology

By detecting the expression of CYP71D55 gene, the resistance of CYP71D55 can be accurately identified, scientific medication use can be guided, and further spread of drug resistance can be alleviated, providing an important reference for the research and management of CYP71D55 gene.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118932105A_ABST
    Figure CN118932105A_ABST
Patent Text Reader

Abstract

The invention provides application of a bromegrass CYP71D55 gene. The nucleotide sequence of the bromegrass CYP71D55 gene is as shown in SEQ ID NO: 1, and the nucleotide sequence of the bromegrass CYP71D55 gene is as shown in SEQ ID NO: 2. The amino acid sequence is as shown in SEQ ID NO: 2; the bromegrass CYP71D55 gene is applied to identification of the resistance of different bromegrass materials to sulfonamide carbonyl triazolinone herbicides. The expression quantity of the brome CYP71D55 gene disclosed by the invention has an important application prospect in research on drug resistance of brome, and meanwhile, a reference basis is provided for precise treatment of drug resistance of brome to sulfonamide carbonyl triazolinone herbicides.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to an application of a brome CYP71D55 gene. Background Art

[0002] Long-term and continuous unscientific application of herbicides can easily lead to the development of weed resistance. Bromus has developed resistance to herbicides, and with the development of non-target resistance, the control of Bromus has become more difficult.

[0003] At present, studies have shown that cytochrome P450 can metabolize herbicides into non-toxic substances through dealkylation, ring methyl hydroxylation, aromatic ring hydroxylation, desulfurization oxidation and catalytic ester bond cleavage, and the increased expression of certain genes in the P450 family will make the originally sensitive weed population resistant to herbicides. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide an application of the brome CYP71D55 gene in view of the deficiencies of the above-mentioned prior art. The expression level of the brome CYP71D55 gene has important application prospects in the study of brome resistance to pesticides, and at the same time provides a reference basis for the precise control of brome resistance to sulfonamide carbonyl triazolinone herbicides.

[0005] To solve the above technical problems, the technical solution adopted by the present invention is: an application of a brome CYP71D55 gene, the nucleotide sequence of the brome CYP71D55 gene is shown in SEQ ID NO: 1; the amino acid sequence of the brome CYP71D55 gene is shown in SEQ ID NO: 2; and the application of the brome CYP71D55 gene in identifying the resistance of different brome materials to sulfonamide carbonyl triazolinone herbicides.

[0006] The invention discloses an application of the brome CYP71D55 gene as a marker for the resistance of different brome materials to sulfonamide carbonyl triazolinone herbicides.

[0007] The invention discloses an application of the brome CYP71D55 gene in identifying brome materials resistant to sulfonamide carbonyl triazolinone herbicides.

[0008] Preferably, the sulfonamide carbonyl triazolinone herbicide includes fluazifop-butyl.

[0009] Preferably, the method for detecting the expression level of the brome CYP71D55 gene is:

[0010] Extracting total RNA from the brome to be tested, and reversely transcribing it into cDNA; using the cDNA as a template, and using CYP71D55-F and CYP71D55-R as primers, performing real-time fluorescence quantitative PCR amplification; and simultaneously setting an internal reference gene Ubiquitin to calculate the relative expression level of the CYP71D55 gene;

[0011] The reaction system of the real-time fluorescence quantitative PCR amplification is: 2× Fast Green qPCR SuperMix 10 μL, 10 μmol forward primer 0.4 μL, 10 μmol reverse primer 0.4 μL, cDNA 1 μL, Nuclease-free water to 20 μL;

[0012] The reaction procedure of the real-time fluorescence quantitative PCR amplification is: pre-denaturation at 94°C for 30s; denaturation at 94°C for 5s, primer annealing at 60°C for 34s and fluorescence signal collection, for a total of 40 cycles; then entering the melting curve reaction;

[0013] The nucleotide sequence of the CYP71D55-F is shown in SEQ ID NO:3; the nucleotide sequence of the CYP71D55-R is shown in SEQ ID NO:4;

[0014] The primers used to amplify the internal reference gene Ubiquitin are Ubiquitin-F and Ubiquitin-R;

[0015] The nucleotide sequence of Ubiquitin-F is shown in SEQ ID NO:5; the nucleotide sequence of Ubiquitin-R is shown in SEQ ID NO:6.

[0016] Compared with the prior art, the present invention has the following advantages:

[0017] The present invention discloses the relationship between the brome CYP71D55 gene and the resistance to sulfonamide carbonyl triazolinone (especially fluzoxasulfone) herbicides, and the expression level of the CYP71D55 gene is positively correlated with the resistance of the brome to fluzoxasulfone. Therefore, whether the brome has metabolic resistance to the herbicide can be identified by detecting the expression level of the CYP71D55 gene, which has guiding significance for timely discovering resistance, guiding scientific use of pesticides in farmland, and alleviating the further spread of resistance. The method for detecting the expression level of brome CYP71D55 provided by the present invention has the advantages of simplicity, high sensitivity, and strong specificity, and has important application prospects in the study of brome resistance, and at the same time provides a reference basis for the precise management of brome resistance.

[0018] The present invention is further described in detail below with reference to the accompanying drawings and embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 This is the RNA electrophoresis detection diagram in Example 2 of the present invention. (Wherein, M is a marker; 1 is the RNA of the HB-1 population; 2 is the RNA of the S population.)

[0020] Figure 2 This is the melting curve corresponding to the detection primer CYP71D55-F / R in Example 3 of the present invention.

[0021] Figure 3 This is the standard curve drawn for the primer CYP71D55-F / R in Example 3 of the present invention.

[0022] Figure 4 This is the melting curve corresponding to the internal reference primer Ubiquitin-F / R in Example 3 of the present invention.

[0023] Figure 5 This is the standard curve drawn for the primer Ubiquitin-F / R in Example 3 of the present invention.

[0024] Figure 6 This is the electrophoresis detection diagram of the primer CYP71D55-F / R amplification product in Example 3 of the present invention. (Wherein, M is Marker; 1 is the amplification product of the internal reference gene Ubiquitin-F / R; 2 is the amplification product of CYP71D55-F / R.)

[0025] Figure 7 The relative expression of CYP71D55 gene in brome resistant and sensitive populations after 24 hours of treatment with fluzoxasulfone and when not treated in Example 4 of the present invention. (The abscissas HB-1_T, S_T, HB-1_CK, and S_CK represent the brome resistant population after application, the brome sensitive population after application, the brome resistant population before application, and the brome sensitive population before application, respectively, and the ordinate represents the relative expression of CYP71D55 gene.) DETAILED DESCRIPTION

[0026] The S population of brome was collected from Kaifeng City, Henan Province, and is a biotype sensitive to fluazifop-butyl. The HB-1 population of brome was collected from Baoding City, Hebei Province, and is a biotype resistant to fluazifop-butyl.

[0027] Example 1

[0028] This example is to obtain the CYP71D55 gene

[0029] The experiment selected the sensitive population S collected from Henan Province and the resistant population HB-1 from Hebei Province.

[0030] 1. Transcriptome sequencing

[0031] When the plants of S and HB-1 populations reached the 3-4 leaf stage, 1 times the recommended field dose of fluazifop-sodium (31.5 g a.i.ha -1 ) were treated with stem and leaf spraying, and the aboveground parts of the plants were sampled before and 24 hours after application. Three replicates were set at each sampling point, for a total of 12 samples.

[0032] 2. Acquisition of CYP71D55 gene Differentially expressed genes were screened based on the transcriptional sequencing results, and the differential signaling pathways were determined through pathway significant enrichment, and gene information and gene sequences were obtained from the sequencing results.

[0033] The nucleotide sequence of the brome CYP71D55 gene is shown in SEQ ID NO:1; the amino acid sequence of the brome CYP71D55 gene is shown in SEQ ID NO:2.

[0034] Example 2

[0035] This example is about the extraction of total RNA from Bromus striata.

[0036] The test selected samples from the sensitive brome population S in Henan Province and the resistant brome population HB-1 in Hebei Province.

[0037] 1. Total RNA Extraction

[0038] Three samples of sensitive brome and resistant brome treated with the sulfonamide carbonyl triazolinone herbicide fluzoxasulfone-methyl for 24 hours and three samples of untreated brome were selected, and total RNA was extracted according to the instructions of the kit to obtain the corresponding total RNA solutions.

[0039] 2. RNA Agarose Gel Electrophoresis

[0040] Take 3 μL of total RNA solution, perform electrophoresis on 1% agarose gel, the voltage is 130V, the electrophoresis time is 20min, and scan with gel imaging. Figure 1 As shown, channel 1 from the left is Maker, channel 2 is S population; channel 3 is HB-1 population. Two clearly distinguishable main bands (28s and 18s) can be seen in UV detection, indicating that the RNA is intact and not degraded.

[0041] Example 3

[0042] This example is the screening of primers for detecting the expression of CYP71D55 gene in Bromus striata

[0043] 1. Reverse transcription (synthesis of the first strand of cDNA)

[0044] (1) Prepare the reverse transcription system shown in Table 1:

[0045] Table 1 Reverse transcription system

[0046]

[0047] (2) Perform reverse transcription reaction on a PCR instrument under the following conditions: 42°C for 15 min, 85°C for 5 s, and incubate at 12°C.

[0048] 2. Primer Design

[0049] (1) The gene sequence of Bromus CYP71D55 was obtained by transcriptome sequencing.

[0050] (2) Design of fluorescence quantitative PCR primers.

[0051] In step (2), primers were designed using Oligo 7.0 software and Primer 5.0 software. The designed primers were screened for specific primers at NCBI to obtain two pairs of primers. The primer sequences, amplified fragment lengths and annealing temperatures are shown in Table 2:

[0052] Table 2 Primer sequences, amplified fragment lengths and annealing temperatures

[0053] Primer name Primer sequence 5`-3` Annealing temperature CYP71D55-F SEQ ID NO:3 57.64 CYP71D55-R SEQ ID NO:4 57.76 Ubiquitin-F SEQ ID NO:5 55.58 Ubiquitin-R SEQ ID NO:6 55.52

[0054] 3. Establishing qPCR Primer Standard Curve

[0055] The cDNA concentrations used in the standard curve were 1000ng, 500ng, 250ng, 125ng, 62.5ng, and 0.

[0056] Real-time quantitative PCR system:

[0057] Table 3 Real-time quantitative PCR system

[0058]

[0059] The real-time quantitative PCR reaction procedure is:

[0060] a. 94℃30s,

[0061] b. 94℃5s,

[0062] c. 60℃34min,

[0063] Repeat bc for 40 cycles;

[0064] d. The temperature range of the melting curve is 60-95℃, and it rises from 60℃ to 95℃ at a rate of 0.5℃ / min.

[0065] The primer amplification efficiency is between 80% and 120%, and the standard curve correlation coefficient R 2The melting curve is used to preliminarily judge whether the primer is usable. The judgment standard is that the curve has only a single sharp peak, and the temperature value of the peak should be near the Tm value. Figure 2 ) and the standard curve ( Figure 3 ) and Ubiquitin-F / R primer melting curve ( Figure 4 ) and the standard curve ( Figure 5 ), the results showed that the required primers met the criteria and could be used for subsequent sequencing verification.

[0066] 4. Gene Amplification

[0067] PCR was performed using cDNA as a template and CYP71D55-F / R and Ubiquitin-F / R as primers, wherein the PCR reaction system was: 2 μL of 2.5 mM dNTP mixture, 2.5 μL of 10×PCR Buffer, 0.5 μL of 10 μM upstream and downstream primers, 0.5 μL of 5 U / μL Taq DNA polymerase, 1 μL of the cDNA sample to be tested, and 18 μL of ddH2O was added to the reaction system to make 25 μL.

[0068] The PCR reaction program was as follows: pre-denaturation at 94°C for 5 min; denaturation at 94°C for 30 s, annealing at 60°C for 45 s, and extension at 72°C for 30 s, for a total of 35 cycles; and extension at 72°C for 5 min.

[0069] 5. Verification of the specificity of primer amplification fragments

[0070] The PCR amplification products corresponding to the primers CYP71D55-F / R and the primers Ubiquitin-F / R were detected by 2% agarose gel electrophoresis and UV light detection. Figure 6 As shown, it was found that the target bands amplified by CYP71D55-F / R primers and Ubiquitin-F / R primers were both single bands, the amplified fragment size was located at 100bp-300bp, and there was no dimer.

[0071] Example 4

[0072] Detection of CYP71D55 gene expression by fluorescence quantitative PCR

[0073] The materials used for gene expression determination are shown in Example 1. First, qPCR verification was performed on the materials collected from S and HB-1 to determine whether the expression level of CYP71D55 in the parallel materials was consistent with the transcriptome sequencing results.

[0074] Fluorescence quantitative test data using 2 -ΔΔCt Perform analysis ( Figure 7), where ΔCt = Ct value of target gene (CYP71D55) - Ct value of internal reference gene (Ubiquitin), ΔΔCt = ΔCt (treatment) - ΔCt (control). SPSS was used to perform independent sample T test and one-way ANOVA analysis on the relative expression of CYP71D55 gene in sensitive and resistant brome populations.

[0075] The results showed that the gene expression in the material was consistent with the transcriptome sequencing results. In the transcriptome sequencing results, the expression of CYP71D55 in the HB-1 population was 8.1 times that of the S population, significantly higher than that of the S population. The qPCR results showed that the expression of CYP71D55 in the R population was 7.9 times that of the S population, also significantly higher than that of the S population.

[0076] The primers for detecting the expression amount of the brome CYP71D55 gene provided by the present invention (i.e., the fluorescent quantitative primers SEQ ID NO: 3-4) have no hairpin structure, do not form primer dimers, specifically amplify a unique identification fragment, and the length of the amplified product is 140 bp. The change of the fluorescence signal is used to monitor the change of the amount of the amplified product in each cycle of the PCR amplification reaction in real time, and the starting template is quantitatively analyzed by the relationship between the Ct value and the standard curve, and the expression amount of the brome CYP71D55 between different materials at different periods is quickly determined, and then the resistance of the brome is determined, which can be used for scientific treatment of drug-resistant brome.

[0077] The brome CYP71D55 gene of the invention can be used in identifying the resistance of different brome materials to sulfonamide carbonyl triazolinone herbicides.

[0078] The brome CYP71D55 gene of the invention is used as a marker of resistance of different brome materials to sulfonamide carbonyl triazolinone herbicides.

[0079] The brome CYP71D55 gene of the invention can be used to identify brome materials resistant to sulfonamide carbonyl triazolinone herbicides.

[0080] The above is only a preferred embodiment of the present invention and does not limit the present invention in any way. Any simple modification, change and equivalent change made to the above embodiment according to the technical essence of the invention still falls within the protection scope of the technical solution of the present invention.

Claims

1. An application of brome CYP71D55 gene, It is characterized in that The nucleotide sequence of the brome CYP71D55 gene is shown as SEQ ID NO: 1; the amino acid sequence of the brome CYP71D55 gene is shown as SEQ ID NO: 2; and the application of the brome CYP71D55 gene in identifying the resistance of different brome materials to sulfonamide carbonyl triazolinone herbicides.

2. According to the use of a brome CYP71D55 gene as described in claim 1, It is characterized in that The sulfonamide carbonyl triazolinone herbicides include fluazifop-butyl.

3. Use of a brome CYP71D55 gene according to claim 1 or 2, It is characterized in that The method for detecting the expression level of the brome CYP71D55 gene is: Extracting total RNA from the brome to be tested, and reversely transcribing it into cDNA; using the cDNA as a template, and using CYP71D55-F and CYP71D55-R as primers, performing real-time fluorescence quantitative PCR amplification; and simultaneously setting an internal reference gene Ubiquitin to calculate the relative expression level of the CYP71D55 gene; The reaction system of the real-time fluorescence quantitative PCR amplification is: 2× Fast Green qPCR SuperMix 10 μL, 10 μmol forward primer 0.4 μL, 10 μmol reverse primer 0.4 μL, cDNA 1 μL, Nuclease-free water to 20 μL; The reaction procedure of the real-time fluorescence quantitative PCR amplification is: pre-denaturation at 94°C for 30s; denaturation at 94°C for 5s, primer annealing at 60°C for 34s and fluorescence signal collection, for a total of 40 cycles; then entering the melting curve reaction; The nucleotide sequence of the CYP71D55-F is shown in SEQ ID NO:3; the nucleotide sequence of the CYP71D55-R is shown in SEQ ID NO:4; The primers used to amplify the internal reference gene Ubiquitin are Ubiquitin-F and Ubiquitin-R; The nucleotide sequence of Ubiquitin-F is shown in SEQ ID NO:5; the nucleotide sequence of Ubiquitin-R is shown in SEQ ID NO:6.